期刊文献+

肌层浸润性膀胱癌转移潜能异质性蛋白质组学研究

Proteome research about metastatic heterogeneity in muscle-invasive bladder cancer
下载PDF
导出
摘要 目的研究肌层浸润性膀胱癌转移潜能异质性,并探讨生物通路在肌层浸润性膀胱癌异质性中的关键性作用。方法同位素标记相对和绝对定量(i TRAQ)技术和二维液相色谱串联质谱(2D-LC–MS/MS)量化和鉴定纯化不同转移风险组膀胱癌差异表达蛋白质,生物信息学方法进一步分析鉴定显著差异表达蛋白质并与既往相关文献的结果进行比较。结果生物通路的改变与浸润性膀胱癌异质性的调节密切相关。代谢相关通路参与了肿瘤的恶性生物学行为。显著改变的代谢通路包括糖酵解/糖异生通路、戊糖磷酸化通路、丙酮酸代谢通路、谷胱甘肽代谢通路等。结论遗传信息处理KEGG通路在决定浸润性膀胱癌恶性表型中起到重要作用。蛋白质量化分析结合KEGG通路分析有利于揭示膀胱癌发病机制并指导膀胱癌分子治疗方法。 Objective To study the metastatic heterogeneity of muscle-invasive bladder cancer(MIBC) and to explore the crucial role of biological pathway change in heterogeneity of MIBC cells. Methods i TRAQ and2D-LC-MS / MS were used to quantify and identify the differently expressed proteins in different metastatic risk groups. Then,the significantly changed proteins were further analyzed by using Arraytrack software. The interested proteins were compared with the data from published literatures to discuss the exact functions. Results The change of biological pathways was intimately related with cancer heterogeneity. Meanwhile,metabolic pathways play important roles in malignant biological behavior. The mainly altered pathways include glycolysis / gluconeogenesis,pentose phosphate, pyruvate metabolism pathway, glutathione metabolism, citrate cycle, etc. Conclusion The KEGG pathways of genetic information processing category play a crucial role in determining the malignant phenotype of MIBC cells. The quantification analysis of proteins combining with the KEGG pathway analysis contributes to screening candidate biomarkers and guides the biological molecular therapy of MIBC.
出处 《实用医药杂志》 2015年第5期446-448,共3页 Practical Journal of Medicine & Pharmacy
基金 国家自然科学基金资助项目(30901481 81372752 81472411) 吴阶平医学基金项目(320.6750.13261)
关键词 肌层浸润性膀胱癌 同位素标记相对和绝对定量技术 生物标记 生物通路 异质性 蛋白质组学 Muscle-invasive bladder cancer i TRAQ Biomarker Biological pathway Heterogeneity Proteome
  • 相关文献

参考文献8

  • 1Ping Miao,Shile Sheng,Xiaoguang Sun,Jianjun Liu,Gang Huang.Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy[J]. IUBMB Life . 2013 (11)
  • 2Feng Yao,Tiejun Zhao,Chenxi Zhong,Ji Zhu,Heng Zhao.LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma[J]. Tumor Biology . 2013 (1)
  • 3Niu Haitao,Jiang Haiping,Cheng Bo,Li Xinhui,Dong Qian,Shao Leping,Liu Shiguo,Wang Xinsheng.Stromal proteome expression profile and muscle-invasive bladder cancer research. Cancer cell international . 2012
  • 4Brijesh M. Madhok,Sashidhar Yeluri,Sarah L. Perry.Targeting Glucose Metabolism An Emerging Concept for Anticancer Therapy. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS . 2011
  • 5Zaidel-Bar Ronen,Itzkovitz Shalev,Ma’ayan Avi,Iyengar Ravi,Geiger Benjamin.Functional atlas of the integrin adhesome. Nature Cell Biology . 2007
  • 6De Sousa E,Melo F,Vermeulen L,Fessler E,et al.Cancer heterogeneity--a multifaceted view. EMBO Reports . 2013
  • 7Cui J,Shi M,Xie D,et al.FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression. Clinical Cancer Research . 2014
  • 8Airley Rachel E,Mobasheri Ali.Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Journal of Chemotherapy . 2007

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部